.png)
CELLINK, CYTENA and DISPENDIX, as part of BICO, the world's top bioconvergence company, are driving advancements in health by providing state-of-the-art technologies such as bioprinters, biomaterials, and liquid handlers. Our objective is to tackle the organ shortage crisis worldwide and accelerate drug development by making cutting-edge technologies accessible to researchers. Our industry-leading expertise allows us to assist scientists in developing more physiologically relevant models and automating workflows to facilitate discoveries in drug development, diagnostics, and synthetic biology. Our technologies have been adopted by thousands of organizations worldwide.